Kobo Biotech Ltd. benchmarking: Perfomance to industry peers

Financial

	Kobo Biotech	Fabino Enterprises	Hemo Organic
Operational Metrics
Financials
5 yr Average ROE	-1.77 %	0.86 %	-361.35 %
5yr average Equity Multiplier	4.06	3.04	-1.56
5yr Average Asset Turnover Ratio	0.54	1.02	0.14
5yr Avg Net Profit Margin	-3.79 %	0.28 %	-763.22 %
Price to Book	0.0	1.19	0.0
P/E	0.0	79.18	40.97
5yr Avg Cash Conversion Cycle	0.0	61.26 Days	100.48 Days
Inventory Days	89.28 Days	58.83 Days	406.93 Days
Days Receivable	0.0	271.0 Days	196.55 Days
Days Payable	147.48 Days	124.87 Days	2776.86 Days
5yr Average Interest Coverage Ratio	0.99	2.22	-250.54
5yr Avg ROCE	11.79 %	2.5 %	37.52 %
5yr Avg Operating Profit Margin	8.83 %	0.74 %	-745.72 %
5 yr average Debt to Equity	1.62	0.28	-0.73
5yr CAGR Net Profit	n/a	43.1 %	n/a
5yr Average Return on Assets	-0.89 %	0.27 %	-33.34 %
Shareholdings
Promoter Holding	44.95 %	56.82 %	16.85 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0